| Target Price consensus revisions : last 18 months |
|
|
|
| Evolution of the average Target Price on INNATE PHARMA |
|
|
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
| Mean consensus |
OUTPERFORM |
| Number of Analysts |
5 |
| Average target price |
7,23 € |
| Last Close Price |
3,83 € |
| Spread / Highest target |
187% |
| Spread / Average Target |
88,4% |
| Spread / Lowest Target |
-21,8% |
Consensus revision (last 18 months)
|
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
